Raia Drogasil (OTCMKTS:RADLY) Sets New 12-Month Low – Time to Sell?

Raia Drogasil S.A. (OTCMKTS:RADLY) shares hit a new 52-week low during trading on Tuesday. The company traded as low as $2.63 and last traded at $2.71, with a volume of 13,437 shares changing hands. The stock had previously closed at $2.76.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised shares of Raia Drogasil to a “buy” rating and set a $5.20 price objective for the company in a report on Sunday, October 18th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Price Performance

The stock has a market cap of $3.52 billion and a P/E ratio of 17.85. The business’s 50-day simple moving average is $3.74 and its two-hundred day simple moving average is $4.07. The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99.

Raia Drogasil (OTCMKTS:RADLY) last released its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. The company had revenue of $2.17 billion for the quarter, compared to the consensus estimate of $2.32 billion. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. Sell-side analysts expect that Raia Drogasil S.A. will post 0.17 EPS for the current year.

About Raia Drogasil

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.